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Centrioles are essential for cilia and centrosome
assembly. In centriole-containing cells, centrioles
always form juxtaposed to pre-existing ones,
motivating a century-old debate on centriole
biogenesis control. Here, we show that trans-au-
toactivation of Polo-like kinase 4 (PLK4), the trigger
of centriole biogenesis, is a critical event in the
spatial control of that process. We demonstrate
that centrioles promote PLK4 activation through
its recruitment and local accumulation. Though
centriole removal reduces the proportion of
active PLK4, this is rescued by concentrating
PLK4 to the peroxisome lumen. Moreover, while
mild overexpression of PLK4 only triggers centriole
amplification at the existing centriole, higher PLK4
levels trigger both centriolar and cytoplasmatic
(de novo) biogenesis. Hence, centrioles promote
their assembly locally and disfavor de novo syn-
thesis. Similar mechanisms enforcing the local
concentration and/or activity of other centriole
components are likely to contribute to the spatial
control of centriole biogenesis under physiological
conditions.
INTRODUCTION
Centrioles are microtubule-based structures essential for cilia
and centrosome formation (Bettencourt-Dias and Glover,
2007; Nigg and Stearns, 2011). In each cell cycle, one and
only one centriole is formed close to an already existing
centriole (canonical biogenesis) (Bettencourt-Dias and Glover,
2007; Nigg and Stearns, 2011). Centrioles can also form
in the absence of a pre-existing centriole (de novo biogenesis).
De novo formation is known to occur in insect species with
development without fertilization (parthenogenesis), as oocytes
normally lose their centrioles during oogenesis (Cunha-Ferreira222 Developmental Cell 35, 222–235, October 26, 2015 ª2015 Elsevet al., 2009). Human cells can also form centrioles de novo
upon laser ablation of their centrosome (La Terra et al., 2005).
In most circumstances, de novo assembly is slower than
the canonical pathway, with centrioles forming in variable
numbers and presumably anywhere in the cell (Cunha-Ferreira
et al., 2009). Intriguingly, the presence of a single centriole
prevents de novo assembly (La Terra et al., 2005; Marshall
et al., 2001). This preference for canonical biogenesis allows
the strict control in timing and number, and for biogenesis to
be regulated by the multitude of signaling proteins, such as
p53, that localize to the centrosome (Bettencourt-Dias and
Glover, 2007; Nigg and Stearns, 2011). How do existing centri-
oles control where new centrioles form? Centrioles might
release an ‘‘inhibitor of centriole biogenesis’’ (Marshall et al.,
2001); alternatively, they might catalyze centriole assembly
by preferentially recruiting centriole precursors or by locally
activating them (Marshall et al., 2001; Rodrigues-Martins
et al., 2007). What could be the nature of such inhibitors/
catalyzers? Regulation of Polo Like Kinase 4 (PLK4), a major
player in centriole biogenesis, might play a critical role in
the spatial control of centriole assembly. In the absence of
PLK4, no centrioles are formed (Bettencourt-Dias et al., 2005;
Habedanck et al., 2005), while in excess, it triggers multiple
centriole formation at the centrosome in cycling cells (canonical
amplification) (Habedanck et al., 2005; Kleylein-Sohn et al.,
2007; Rodrigues-Martins et al., 2007) and de novo assembly
in acentriolar systems, such as Drosophila unfertilized eggs
(Peel et al., 2007; Rodrigues-Martins et al., 2007). However,
de novo is slower than the canonical centriole biogenesis
observed in fertilized Drosophila eggs expressing similar
PLK4 the same levels (Rodrigues-Martins et al., 2007). This
supports a model where centrioles catalyze their own
assembly and where PLK4 activity is a limiting factor in both
canonical and de novo biogenesis. PLK4 function is likely
to be determined by its concentration and regulation of its
kinase activity (Zitouni et al., 2014). While PLK4 levels are
negatively controlled by autophosphorylation on a specific
degron sequence recognized by the SCF-Slimb/bTrCP ubiqui-
tin ligase complex (Cunha-Ferreira et al., 2013; Holland et al.,
2010; Klebba et al., 2013), little is known about the regulation
of its kinase activity. Here, we set out to investigate howier Inc.
Figure 1. Drosophila PLK4 Thr172 Is a
Conserved Phosphorylation Site Required
for Kinase Activity
(A) Scheme of Drosophila PLK4 showing the Ki-
nase domain, the Cryptic Polo-Box (PB1 and PB2)
and the Polo-Box 3 (PB3). Sequence alignment of
part of human (Hs) and Drosophila (Dm) PLK1 and
PLK4 activation segment: the threonine residue
within the T-loop whose phosphorylation leads to
PLK1 activation (Thr210/Thr182 in human and
Drosophila PLK1, respectively) is highly conserved
in PLK4 (Thr170/Thr172 in human and Drosophila,
respectively). Residues are highlighted in red.
(B) PLK4 T172A mutant has residual catalytic
activity. DMEL cells expressing pMT-GFP-
PLK4(WT), GFP-PLK4(T172A) (Thr172 mutated to
alanine), and GFP-PLK4(KD) (kinase dead) after
depletion of endogenous PLK4 (ePLK4RNAi) were
probed by western blot with p-PLK4 Ser293 and
GFP antibodies. PLK4(WT) was loaded in excess
to have similar amounts of the different constructs
and thus facilitate comparison of the proportion of
p-PLK4 Ser293 (see also Figure S1B). Autophos-
phorylation at Ser293 residue (p-PLK4 Ser293) is
used as a readout of PLK4 activity (Cunha-Ferreira
et al., 2013). Quantification of the ratio of PLK4
phosphorylated at Ser293 to the total amount of
PLK4 (GFP-PLK4) is shown; ratios were normal-
ized to the WT kinase. Data are the average of
three experiments ± SEM (*p < 0.05, **p < 0.01,
t test) (see also Figure S1A).
(C and D) PLK4 T172A mutant expression cannot
rescue loss of PLK4. (C) Representative images of
DMEL cells expressing act5-Myc-PLK4(WT), Myc-PLK4(T172A), or Myc-PLK4(KD) (in green) after depletion of endogenous PLK4 (ePLK4 RNAi). D-PLP
(Drosophila Pericentrin-Like Protein, a centriole marker, in red) and DAPI (DNA, in blue). Dashed lines represent the individual cells outline as judged by the D-PLP
background signal. Arrows indicate transfected cells. T172A forms agglomerates in the cytoplasm, as described for KD (Klebba et al., 2013). Scale bar represents
5 mm. (D) Quantification of centriole number per cell. Data are the average of 3 experiments ± SEM (***p < 0.0001, Pearson’s c2 test). Similar results in centriole
biogenesis were obtained using pMT-GFP-PLK4 constructs (not shown).PLK4 kinase activity is regulated and whether centrioles cata-
lyze this process.
RESULTS
Phosphorylation of Drosophila PLK4 Thr172 Is Required
for Its Catalytic Activity
Activation of the founding member of the Polo family (PLK1) in-
volves phosphorylation of one critical residue within its T-loop
in the catalytic domain (Archambault andCarmena, 2012; Zitouni
et al., 2014), which is highly conserved in PLK4 (Figure 1A). While
different mechanisms may be involved in PLK4 activation, we
first asked whether this residue in PLK4 had a role in its activa-
tion. We observed phosphorylation of the equivalent residue in
PLK4 (Threonine 172) using mass spectrometry (not shown).
To confirm the role of Thr172 phosphorylation for PLK4 activity,
we used two readouts: the ability of PLK4 to trans autophosphor-
ylate in a residue located in its degron (Ser293; Cunha-Ferreira
et al., 2013; Figure 1B) and its ability to phosphorylate an exog-
enous substrate (myelin basic protein [MBP]; Figure S1A). The
catalytic activity of PLK4(T172A), a mutant where Thr172 was
mutated to alanine to mimic its non-phosphorylated state, was
significantly reduced as compared with PLK4(WT) (Figures 1B
and S1A). Kinase dead PLK4 (KD; bears three mutations in theDevelopmkinase catalytic site: K43M, K22M, and D156A; Rodrigues-Mar-
tins et al., 2008) showed no activity as expected. It is important to
note that the T172A mutation preventing activation of PLK4 also
affected its steady-state stability, as the mutant is much more
stable, similar to a kinase dead PLK4 (Figure S1B). This is consis-
tent with previous studies demonstrating that a catalytically inac-
tive PLK4 is more stable as it cannot autophosphorylate and
target itself for degradation (Cunha-Ferreira et al., 2013; Holland
et al., 2010; Klebba et al., 2013). Moreover, impairment of PLK4’s
ability to be phosphorylated at Thr172, from hereinafter called
‘‘PLK4 activation,’’ also had strong consequences in its centriole
biogenesis function (Figures 1C and 1D). Similar to the kinase
dead, expression of PLK4(T172A) could not rescue the accumu-
lation of cells with an abnormally low number of centrioles (less
than two) that arose from depletion of endogenous PLK4 (Fig-
ures 1C and 1D). Together, these data suggest that though
Thr172 non-phosphorylated PLK4 has residual catalytic activity
(Figure 1B), this is not sufficient to drive centriole biogenesis (Fig-
ures 1C and 1D).
PLK4 Regulates Its Own Kinase Activity
by Autophosphorylating Thr172
The identity of the kinase that activates PLK4 in an unperturbed
cell is hitherto unknown. The activating phosphorylation of theental Cell 35, 222–235, October 26, 2015 ª2015 Elsevier Inc. 223
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Figure 2. Drosophila PLK4 trans-Autophosphorylates the T-loop Residue Thr172
(A) PLK4 autophosphorylates Thr172 directly in bacteria. Soluble fractions of GST-PLK4(WT), co-expressed or not with l-ppase, andGST-PLK4(KD) were probed
by western blot with p-PLK4 Thr172 and GST. PLK4(WT) is hyperphosphorylated.
(B) PLK4 catalytic activity is needed for Thr172 phosphorylation in cells. DMEL cells expressing pMT-GFP-PLK4(WT), GFP-PLK4(T172A), GFP-PLK4(KD), GFP-
PLK4(ND) (non-degradable), and GFP-PLK4(KDND) after depletion of endogenous PLK4 (ePLK4 RNAi) were probed by western blot for p-PLK4 Thr172 and GFP.
PLK4(WT) was loaded in excess to have similar amounts of the different constructs and thus facilitating comparison of the proportion of p-PLK4 Thr172 (see also
Figure S1B). Quantification of the ratio of PLK4 phosphorylated at Thr172 to the total amount of PLK4 (GFP-PLK4) is shown; ratios were normalized to the WT
kinase. Data are the average of three experiments ± SEM (n.s., not significant; *p < 0.05, **p < 0.01, t test). Attesting to the specificity of the antibody, T172A lane
does not show pThr172 signal (see also Figure S2A).
(C) PLK4 trans-autophosphorylates the Thr172 residue in vitro. Autophosphorylation of increasing concentrations of dephosphorylated His-MBP-PLK4 (50 to
800 mM) occurred 10 min after ATP addition. Samples were probed by western blot with p-PLK4 Thr172 and His. Quantifications of the intensity of His-PLK4
phosphorylated at Thr172 and of the intensity of total His-PLK4 are shown; values were normalized to the highest concentration analyzed. Note that PLK4
autophosphorylation (p-PLK4 Thr172) shows a trans, non-linear behavior, different from the PLK4 total levels curve (see also Figures S2B and S2C).
(D and E) PLK4 trans-phosphorylates at Thr172 in cells. (D) Schematic representation of PLK4 trans-phosphorylation experiment. (E) Indicated combinations of
pMT-GFP-PLK4(WT), act5-Myc-PLK4(KD), pMT-GFP(empty), and act5-Myc(empty) constructs were expressed in DMEL cells after depletion of endogenous
PLK4 and analyzed by western blot with antibodies against GFP to detect GFP-PLK4(WT) and Myc to detect Myc-PLK4(KD). Note that in the presence of
PLK4(WT), PLK4(KD) becomes phosphorylated (lower mobility bands), as detected by p-PLK4 Thr172 antibody.T-loop of a kinase can either be mediated by another kinase
(e.g., PLK1; Zitouni et al., 2014), or it can be autocatalytic (e.g.,
Aurora A; Adams, 2003). Stress-activated protein kinases
(SAPKKK; Nakamura et al., 2013) can phosphorylate human
PLK4 Thr170, the equivalent residue to Drosophila Thr172 (Fig-
ure 1A) upon cellular stress. However, multiple RNAi screens in
unperturbed cells failed to identify a kinase whose activity is
required for PLK4’s function (Balestra et al., 2013; Bettencourt-224 Developmental Cell 35, 222–235, October 26, 2015 ª2015 ElsevDias et al., 2005; Brownlee et al., 2011; Dobbelaere et al.,
2008; Goshima et al., 2007). Since PLK4 kinase domain can au-
tophosphorylate in vitro (Dodson et al., 2013), we proceeded to
test whether PLK4 autoactivates in a normal cell cycle.
We generated and tested a phospho-specific antibody
(p-PLK4 Thr172) in vitro and cycling cell extracts (see loss of
signal upon phosphatase treatment and T172A mutation in Fig-
ures 2A, 2B, and S2A). Full-length bacterially expressedier Inc.
GST-PLK4(WT) showed Thr172 phosphorylation and reduced
gel mobility, suggestive of autophosphorylation, which was not
observed upon phosphatase co-expression (l-ppase) (Shrestha
et al., 2012) or expression of PLK4(KD) (Figure 2A). These results
show that PLK4 kinase catalytic activity is required and sufficient
for its autophosphorylation at Thr172 in vitro. We observed the
same result by adding ATP to dephosphorylated His-MBP-
PLK4(WT) (Figure S2B). Autophosphorylation of Thr172 was
observed early upon ATP addition and increased with time (Fig-
ure S2B), showing that Thr172 is able to autophosphorylate. To
test whether PLK4 Thr172 autophosphorylation activates
PLK4, we compared the catalytic activity of PLK4 species with
different levels of phosphorylation in this residue (Figure S2C).
Our results show that PLK4 with higher levels of phosphorylation
in Thr172 was more efficient in substrate phosphorylation (Fig-
ure S2C), suggesting that Thr172 phosphorylation correlates
with activity. Although our data do not exclude that full PLK4 acti-
vation may require other autophosphorylated residues (Klebba
et al., 2015a), it strongly suggests that Thr172 is important.
Finally, we asked whether PLK4 also autoactivates in cells and
found that Thr172 was not phosphorylated in the absence of
endogenous PLK4 (Figure 2B) if only the KD mutant is ex-
pressed. Furthermore, we observed the same results even
upon expression of very high PLK4 levels (PLK4 mutant that
cannot be targeted for degradation, ND, and PLK4 non-degrad-
able KD, KDND (Cunha-Ferreira et al., 2009; Figure 2B). These
results show that PLK4 can autoactivate in cells.
Kinase autophosphorylation can be achieved through multiple
molecular mechanisms, which result in different kinetic proper-
ties. While mps1, a kinase involved in mitotic checkpoint
signaling, autophosphorylates and activates in trans (Jelluma
et al., 2008; Kang et al., 2007; Mattison et al., 2007), others auto-
phosphorylate in cis (DeNicola et al., 2013). To understand the
kinetics of PLK4 autophosphorylation (cis versus trans), we
investigated the level of phosphorylation at Thr172 by adding
ATP to different concentrations of dephosphorylated His-MBP-
PLK4(WT) (Figure 2C). Autophosphorylation of Thr172 increased
nonlinearly with increase in PLK4 concentration (Figure 2C),
showing that Thr172-dephosphorylated PLK4 is able to autoac-
tivate in trans. To confirmPLK4 can autophosphorylate in trans in
cells at Thr172, we simultaneously expressed GFP-PLK4(WT)
andMyc-PLK4(KD) in the absence of endogenous PLK4 (Figures
2D and 2E). While individually expressed PLK4(WT) is autophos-
phorylated at Thr172 (left lane), PLK4(KD) is not (middle lane).
However, co-expression of both the active (WT) and inactive
kinases (KD) led to phosphorylation of PLK4(KD) (right lane) by
the co-expressed active PLK4(WT), demonstrating autophos-
phorylation in trans (Figures 2D and 2E).
PLK4 Activation Is Dependent on Its Localized
Accumulation
To investigate the implications of a PLK4 trans-autoactivation
mechanism in the spatial control of centriole biogenesis, we
generated a simple mathematical model of PLK4 activity. This
model takes into account the synthesis of a ‘‘basal form’’ of
PLK4 (non-Thr172 phosphorylated, with residual catalytic activ-
ity), which is activated through phosphorylation of Thr172 and
subsequently targeted for degradation by autophosphorylation
in the degron (B, A*, and A**, respectively, in Figure 3A). We positDevelopmtwo alternative scenarios for PLK4 activation by cis- or trans-au-
tophosphorylation (Figures 3A and 3B). In contrast to a scenario
in which PLK4 autophosphorylates in cis (or is phosphorylated
by unknown kinases), the positive feedback resulting from
PLK4 trans-autophosphorylation gives rise to a threshold of total
PLK4 concentration (Figure 3B) below which there is little PLK4
activation, reflecting the unlikely encounters between two
PLK4 molecules.
An important output of incorporating PLK4 trans-autoactiva-
tion in our model is that PLK4 is only activated when sufficiently
concentrated (Figure 2C). Since PLK4 localizes to the centro-
some, it is possible that the organelle acts as a ‘‘PLK4 concen-
trator’’ so that it reaches supra-threshold concentrations. To
assess this possibility, we elaborated a two-compartment model
featuring an exchange of all PLK4 forms between the cytoplasm
and the centrosome (Figure 3C), assuming that the volume ratio
of the two compartments is 2,000 (Decker et al., 2011), the ex-
change of PLK4 is biased toward the centrosome, and PLK4
basal catalytic activity is 20 times lower than that of the activated
PLK4 (phosphorylated at Thr172; Figure 1B). The model indi-
cates that normal PLK4 production can be tuned so that it elicits
robust PLK4 accumulation and activation at the centrosome but
not in the cytoplasm (Figure 3D), thus preventing centriole forma-
tion in the cytoplasm. If this holds true, the model suggests that
(Figure 3D) (1) the absence of PLK4 recruitment to the centro-
some should lead to little PLK4 trans-autoactivation (Figure 3D,
no centrosome and no PLK4 overexpression); (2) concentrating
PLK4 elsewhere in the cell should be sufficient to activate it; (3)
PLK4 overexpression at low levels should lead to a higher pro-
portion of activated PLK4 at the centrosome and thus canonical
amplification or to de novo centriole biogenesis in the absence of
the centrosome, as reported before (Rodrigues-Martins et al.,
2007) as PLK4 is no longer sequestered by this organelle (Fig-
ure 3D, PLK4 overexpression +); (4) PLK4 overexpression at
high levels should produce a higher proportion of active PLK4
forms anywhere in the cytoplasm, therefore eliciting de novo
biogenesis even in the presence of a pre-existing centrosome,
thus overriding the principle of de novo biogenesis inhibition by
the centrosome (Marshall et al., 2001; Rodrigues-Martins et al.,
2007) (Figure 3D, PLK4 overexpression ++). We decided to test
the predictions that had not been tested in the literature, i.e.,
(1), (2), and (4).
The Centrosome Is the Physiological PLK4
Concentrator
We experimentally tested whether PLK4 trans-activation in
Thr172 is dependent on local concentration of PLK4 at the
centrosome (prediction 1). We first analyzed whether non-phos-
phorylatable PLK4(T172A) can localize to the centrosome.
Indeed, similar to PLK4(WT), PLK4(T172A) localized to the
centrosome (Figure 4A). We then tested whether abrogation of
PLK4 recruitment to the centrosome would prevent its trans-
activation by depleting Asterless (Asl, CEP152 in vertebrates),
a molecule needed for PLK4 recruitment to the centrosome
(Dzhindzhev et al., 2010; Figures 4B–4E). Interestingly, we have
shown that PLK4(KD), which is not phosphorylated in Thr172
(Figure 2), can still interact with Asl (Cunha-Ferreira et al.,
2013). Indeed, depletion of Asl led to impaired recruitment of
PLK4(WT) to the centrosomes (Figures 4B and 4C) and to aental Cell 35, 222–235, October 26, 2015 ª2015 Elsevier Inc. 225
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(A) Reaction diagrams representing the cis- and
trans-autophosphorylation of PLK4 from a non-
Thr172 phosphorylated ‘‘basal form’’ with residual
catalytic activity (B, in gray) to an activated form
phosphorylated in the T-loop residue Thr172 (A*,
in green) and to doubly phosphorylated form tar-
geted for degradation (A**, in green). Dark arrows
indicate the critical flux. Dashed arrows indicate
the kinases catalyzing the phosphorylation steps.
When the catalyst and the substrate are the same,
the phosphorylation is in cis and kinetic is first
order, linear. When the catalyst and substrate
differ the kinetics is non-linear. Top arrow de-
scribes the translated PLK4 that enters the sys-
tem. Lateral outgoing arrows describe constitutive
(thinner) and both constitutive and degron-
induced (thicker) elimination of PLK4.
(B) Stable steady-state concentrations of the
activated and degradation-targeted PLK4
(measured as A = A* + A**) as a function of the rate
of PLK4 expression (parameter s) in a cis (contin-
uous red line) and in a trans-autophosphorylation
mode (continuous green line).
(C) Reaction diagram representing the trans-au-
tophosphorylation of PLK4 in a two-compartment
model describing the conversion between the
three forms and their partitioning between the
cytoplasm and the centrosome.
(D) The pie charts represent the proportion of basal (in gray) and activated (in green) forms both in the cytoplasm and centrosome, in the presence (+ centrosome,
left) and in the absence of centrosome ( centrosome, right). Three scenarios are illustrated: normal PLK4 production rate in the WT (s = 0.1, top, ), moderate
overexpression (s = 1, middle, +) and high overexpression (s = 10, bottom, ++). Note that (1) the proportion of activated PLK4 is always higher at the centrosome
than cytoplasm; (2) within the same levels of overexpressed PLK4 (+ or ++), centrosome removal leads to an increase in the proportion of activated PLK4 in the
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40, b = 2, a = 40, c = 5, p = 10, d = 1, dc = 40, r = 2000, r1 = 5 parameters r2 = 1. For detailed description of the models, see Supplemental Information.reduction in the number of centrosomes (Figure 4D), as reported
(Dzhindzhev et al., 2010). Concomitantly, we saw a reduction in
the ratio of PLK4 phosphorylated in Thr172 (Figure 4E). These re-
sults corroborate our hypothesis that localization of PLK4 at the
centrosome is normally required for its activation. Finally, to test
this hypothesis in a more definitive manner, we investigated the
ratio of activated PLK4(WT) in normal cells versus acentrosomal
cells. We generated acentrosomal cells by depleting an essen-
tial component of the centriole, SAS-6 (Peel et al., 2007; Ro-
drigues-Martins et al., 2007), for several rounds of cell division
(more than eight rounds). As cells divide normally without being
able to duplicate their centrioles, the population of cells with
abnormally low number of centrioles (zero to one) increases to
almost 100% (Rodrigues-Martins et al., 2007) (SAS-6 RNAi;
Figure 5C). We compared the ratio of activated PLK4 (p-PLK4
Thr172) in PLK4(WT)-expressing cells with and without centri-
oles (mCherry or SAS-6 RNAi, respectively; Figure 5D, left).
We detected p-PLK4 Thr172 in cells with centrioles, but not in
acentriolar cells. As PLK4 becomes more active at the centro-
some, it is possible that it also autophosphorylates more in its
degron, targeting itself for degradation (Cunha-Ferreira et al.,
2013; Klebba et al., 2013). In agreement with this, we observed
that PLK4 was more stable in acentriolar cells (SAS-6 RNAi;
Figure S3A).226 Developmental Cell 35, 222–235, October 26, 2015 ª2015 ElsevTogether, these results strongly support ‘‘prediction 1’’ that
PLK4 trans-activation is normally dependent on its recruitment
and concentration at the centrosome but does not formally
exclude the possibility that centrosome molecular components
catalyze PLK4 trans-autophosphorylation. We tested ‘‘predic-
tion 2’’: whether concentration of overexpressed PLK4 alone
outside of the centrosome is sufficient to promote PLK4 trans-
autophosphorylation in cells by accumulating it on the peroxi-
some lumen or artificially on beads.
We targeted PLK4 to the peroxisome lumen using the SKL tag,
a C-terminal peroxisome-targeting sequence responsible for the
import of the majority of peroxisomal proteins into that organelle
(Gould et al., 1989) (Figure 5A). Whereas PLK4(WT) always local-
ized to the centrosomes, PLK4(SKL) was scattered in foci
throughout the cytoplasm. In 58% of cells, PLK4(SKL) co-local-
ized only with the peroxisomal marker mCherry-SKL, while 39%
of the cells showed co-localizationwith both the peroxisome and
the centrosome (Figure 5B). We then removed the centrosomes
from cells with prolonged SAS-6 RNAi so that PLK4(SKL) could
no longer localize to centrosomes but only to peroxisomes,
hence focusing on the consequences of localizing PLK4 on a
different structure than the centrosome (Figure 5C). Remark-
ably, we observed a very strong signal for p-PLK4 Thr172 (Fig-
ure 5D, middle, SAS-6 RNAi), showing that enforced PLK4ier Inc.
Figure 4. Localization of PLK4 to the Centriole Is Important for Its Activation
(A) PLK4(T172A) can localize to the centrosome. Structured illumination images of DMEL cells expressing pMT-PLK4(WT)-GFP and GFP-PLK4(T172A) after
depletion of endogenous PLK4 (ePLK4 RNAi). Cells were immunostained with Asterless (Asl, in red) and D-PLP (in blue) antibodies. Scale bar represents 5 mm.
(legend continued on next page)
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concentration is sufficient to lead to its activation in cells. We
also detected an increase in reduced gel mobility forms of total
PLK4 when at the peroxisome (PLK4(SKL); Figure 5D, left and
middle), suggesting that PLK4 might be shielded from phospha-
tases and/or the SCF-mediated degradation machinery when
concentrated inside that organelle, as opposed to the cytoplasm
(PLK4(WT) SAS-6 RNAi) and the centrosome (PLK4(WT)
mCherry RNAi) ((Brownlee et al., 2011); note that the antibody
against total PLK4 does not recognize a fraction of hyperphos-
phorylated PLK4 that migrates slowly and is recognized by the
p-PLK4-Thr172 antibody). Furthermore, the ratio of Thr172
phosphorylated PLK4 to total PLK4 at the centrosome
(PLK4(WT)) and at the peroxisome (PLK4(SKL)) was dependent
on PLK4 concentration, as expected (Figure 5E). Although
PLK4 was highly active at the peroxisome lumen, we did not
observe centriole formation there, likely due to the lack of sub-
strates required for centriole biogenesis within that organelle.
In fact, Ana2/STIL, a substrate and recently shown activator of
PLK4 (Moyer et al., 2015), was not observed at the peroxisome
(Figure S3B).
Finally, we corroborated these findings by artificially concen-
trating GFP-PLK4(WT) on beads that bind to more than one
GFP molecule. After GFP-PLK4(WT) immunoprecipitation from
cell extracts, with consequent concentration on the beads, we
observed an increase in reduced gel mobility forms and Thr172
phosphorylation independently of the presence of centrosomes
(Figure 5D, right). We conclude that, similar to the peroxisome
targeting in cells, PLK4-enforced immobilization on beads during
immunoprecipitation enables trans-autoactivation of PLK4.
Together, the experiments above described show that the
centrosome is a potent promoter of PLK4 activation and that
this likely works in part through recruitment and concentration
of PLK4, as replacing the centrosome by the peroxisome or
beads rescues PLK4’s trans-autoactivation in Thr172.
High Levels of PLK4 Can Overcome the De Novo
Biogenesis Inhibition
Finally, we tested predictions 3 and 4: that in the presence of
centrioles, low levels of PLK4 should promote only canonical
amplification, while high levels of PLK4 should overcome the
de novo biogenesis inhibition, leading to the very unusual co-
occurrence of both canonical and de novo amplification. In this
case, PLK4 levels would be sufficient to lead to its activation
and consequent centriole biogenesis, anywhere in the
cytoplasm.
We chose Drosophila spermatogenesis as an experimental
system to test our predictions as it provides several advantages
(Figure 6A): (1) cells within 16-cell cysts are in G2 and have two
centrosomes, each with two very long (1.25 mm) easily detect-
able centrioles (inset in Figure 6A), and (2) using Bam promoter(B–E) Delocalization of PLK4 from the centrosome, through Asl depletion, leads t
RNAi as negative control) for 4 days, after depletion of endogenous PLK4 (eP
(B) Representative structured illumination images. Asl is in red, and D-PLP is in b
(C) Depletion of Asl was confirmed by western blot. Actin was used as a loading
(D) Quantification of centriole number per cell. Data are the average of three exp
(E) Cell extracts were probed by western blot with p-PLK4 Thr172 and GFP. mC
proportion of p-PLK4 Thr172. Quantification of the ratio of PLK4 phosphorylate
normalized to the control. Data are the average of three experiments ± SEM (*p <
judged by the D-PLP background signal. Enlargements of the centrosomes indic
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express GFP-PLK4 at different levels by simply growing the
same flies at different temperatures as Gal4 expression is very
sensitive to temperature. Indeed, we found that flies grown at
16C and 25C overexpress very low and high amounts of
PLK4, respectively (Figure 6B). While control flies (no PLK4 over-
expression) consistently showed two WT centrosomes, each
with two centrioles, at all temperatures (type I, shown only for
25C in Figures 6C–6F), we observed centriole amplification,
starting in the 16-cell cyst, in PLK4 overexpressing flies grown
at all temperatures (Figures 6C and 6D). The number of centrioles
increased with PLK4 overexpression levels (Figures 6C and 6D).
At low levels of PLK4 overexpression (16C), we found that
25% of the cells had only two centrosomes, each with several
centrioles forming a rosette (type III; Figures 6C and 6E). Thus,
low PLK4 overexpression promotes canonical amplification in
spermatocytes, as previously described in many cell types (Cu-
nha-Ferreira et al., 2009; Kleylein-Sohn et al., 2007). Strikingly, in
the remaining 75% of the spermatocytes, we detected two ro-
settes and additional supernumerary clusters of centrioles,
each containing one or more centrioles (we called them centro-
somes for simplicity, type IV; Figures 6C, 6E, and 6F), suggesting
the co-occurrence of canonical and de novo amplification in the
same cell. In agreement with our model, we observed that the
number of de novo formed centrosomes increased with PLK4
levels (Figures 6E and 6F), showing that high levels of PLK4 in
the cytoplasm promote de novo biogenesis even in the presence
of centrioles.
Importantly, we never detected de novo formed centrioles in
the presence of WT centrosomes (with two centrioles) (type II;
Figure 6E), suggesting canonical biogenesis is favored to de
novo assembly. This result strongly supports our model in which
the centrosome is a natural concentrator of PLK4, thus promot-
ing its activation.
DISCUSSION
Why centrioles normally form close to existing centrioles is an
intriguing question that has fueled debates about the origin of
centrioles as self-replicating entities. We asked how control of
the activity of PLK4 contributes to the spatial control of centriole
formation. We show that phosphorylation of the conserved
Thr172 T-loop residue is essential for PLK4 kinase activity and
function in centriole biogenesis (Figure 1). Furthermore, as
PLK4 trans-autophosphorylates Thr172, hence autoactivates
(Figure 2), PLK4’s activation critically depends on its concentra-
tion (Figures 3 and 5), and we demonstrate that the centrosome
acts as a natural PLK4 concentrator (Figures 4 and 5). Our data
show that in a centrosome-containing cell, given the naturally
low expression of PLK4, its full activation can only be attainedo its reduced activation. DMEL cells were depleted of Asl (Asl RNAi) (mCherry
LK4 RNAi), and followed by transient transfection with pMT-PLK4(WT)-GFP.
lue. Scale bar represents 5 mm.
control.
eriments ± SEM (***p < 0.0001, Pearson’s c2 test).
herry control sample was loaded in excess to facilitate the comparison of the
d at Thr172 to the total amount of PLK4 (PLK4-GFP) is shown; ratios were
0.05, t test). In (A) and (B), dashed lines represent the individual cells outline as
ated by the arrowheads are shown.
ier Inc.
Figure 5. Concentrating PLK4 Is Sufficient for Its Activation
(A) Scheme of Drosophila PLK4 with peroxisome-targeting tripeptide (SKL).
(B) PLK4(SKL) is targeted to the peroxisome. Immunostaining is shown of DMEL cells expressing pMT-GFP-PLK4(WT) or GFP-PLK4(SKL) and act5-mCherry-
SKL (peroxisomal marker, in red) with D-PLP (in blue). Percentage of cells with PLK4(SKL) localizing to the peroxisome (P), centrosome (C), and both peroxisome
and centrosome (P+C) is indicated in each merged image. Dashed lines represent the individual cells outline as judged by the D-PLP background signal.
Enlargements of the indicated areas are shown. Scale bar represents 10 mm.
(C and D) PLK4 is activated at the peroxisome and on beads. Expression of pMT-GFP-PLK4(WT) or GFP-PLK4(SKL) after depletion of SAS-6 (SAS-6 RNAi;
mCherry RNAi as negative control) in DMEL cells for 12 days. (C) Quantification of centriole number per cell (***p < 0.0001, Pearson’s c2 test). (D) Cell extracts
were probed by western blot with p-PLK4 Thr172 and PLK4 antibodies.mCherry control samples were loaded in excess to have similar amount of PLK4 and thus
(legend continued on next page)
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upon concentration at the centrosome, thus explaining why
daughter centrioles are formed close to their mothers, thus
resembling a self-replicating process. At sufficiently high levels
of PLK4 expression, however, centrosomes no longer inhibit
de novo formation (Figures 6 and 7).
Our data also explain other conundrums. It suggests that in the
absence of the centrosome, PLK4 remains in the cytoplasm
where it is more stable, thus leading to a higher cytoplasmic con-
centration than it normally exists in centrosome-containing cells.
This setting increases the likelihood of stochastic encounters be-
tween trans-autoactivating PLK4 molecules in the cytoplasm
and consequently favors de novo centriole formation (La Terra
et al., 2005) (Figures 3 and S3). In centrosome-containing cells,
however, recruitment of PLK4 to the centrosome disfavors its
accumulation and autoactivation in the cytoplasm (Figures 3,
6, and 7), hence preventing de novo synthesis. This provides
the first explanation for the fact that centrosomes do not nor-
mally form de novo in centrosome-containing cells (La Terra
et al., 2005; Uetake et al., 2007). In agreement with this, accumu-
lation of active PLK4 by any other means, such as preventing its
degradation, also leads to de novo assembly (Wang et al., 2011).
Regulation of centriole biogenesis by PLK4 autophosphorylation
is similar to better studied processes of polarity establishment,
such as the selection of bud site in budding yeast (Li and Bower-
man, 2010). In this system, in the absence of spatial cues,
intrinsic mechanisms, including positive feedback loops, amplify
small and stochastic asymmetries, thus breaking symmetry to
establish polarity and to form one bud. If spatial cues such as
bud scars are present they orient polarity by biasing the site of
amplification of asymmetry. Here, the centriole is the entity that
biases the site of amplification. Similar local positive feedback
circuits may operate in the spatial inheritance of other cellular
structures.
Our and others work suggest that PLK4 is translated and re-
cruited to the centrosome where it accumulates (Cizmecioglu
et al., 2010; Dzhindzhev et al., 2010; Fode et al., 1996; Hatch
et al., 2010; Sillibourne et al., 2010; Sonnen et al., 2012) until it
reaches a threshold that quickly leads to full activation of the ki-
nase, which is essential to trigger centriole biogenesis. Active
PLK4 will then target itself for degradation (Cunha-Ferreira
et al., 2013; Holland et al., 2010; Klebba et al., 2013). It is likely
that both activation and degradation of PLK4 at the centrosome
and in the cytoplasm might be further regulated by many vari-
ables such as (1) phosphorylation of other residues in PLK4
(Klebba et al., 2015a), (2) state of oligomerization of PLK4
(Klebba et al., 2015a, 2015b), (3) interactions with scaffold pro-
teins such as Asl/CEP152 (Klebba et al., 2015b), (4) interactions
with its substrates and recently shown activators such as Ana2/
STIL (Moyer et al., 2015; Ohta et al., 2014), with phosphatases
(Brownlee et al., 2011), and other proteins (Xu et al., 2014). In
the future, it will be critical to study the regulation of the ‘‘acti-
vating’’ and degron-phosphorylation events in PLK4 and howfacilitating comparison of the proportion of p-PLK4 Thr172 (see also Figure S3A). G
blot. Quantification of the ratio of PLK4 phosphorylated at Thr172 to the total am
(E) PLK4 Thr172 phosphorylation is proportional to PLK4 concentration. DMEL c
were analyzed by western blot with p-PLK4-Thr172 and PLK4 antibodies. The rati
were normalized to the 150 mM CuSO4-induced GFP-PLK4(WT) control. All PLK
quantification in (D) and (E) (see also Figure S3B).
230 Developmental Cell 35, 222–235, October 26, 2015 ª2015 Elsevthey generate a lag time during which PLK4 can be active to
phosphorylate its substrates in the right place and at the right
time. In addition, it will be important to understand when and
how during the cell cycle PLK4 reaches its critical concentration
threshold to trigger centriole assembly.
Catalysis of centriole biogenesis at existing centrioles may
present advantages to the eukaryotic cell, namely the control
of centriole number and localization. In fact, de novo centrioles
form in random numbers and locations (Bettencourt-Dias and
Glover, 2007; La Terra et al., 2005; Rodrigues-Martins et al.,
2007; Shang et al., 2002), while centrioles form close to existing
centrioles in all known species that have centrioles. This is true
for species that have centrioles within the context of centro-
somes, such as most animals, and also in species that have
many centrioles forming cilia (called basal bodies) at the cortex,
such as ciliates (Carvalho-Santos et al., 2011). Daughter centri-
oles form and remain engaged to their mothers; only in mitosis
they come apart and become competent to nucleate daughters,
ensuring centriole duplication only occurs once per cell cycle
(Nigg and Stearns, 2011). Hence, spatial regulation of biogenesis
enforces control of centriole number. Spatial control is also
important for geometrical cell organization and movement, as
it defines the localization of microtubule organizing centers,
such as centrosomes and cilia/flagella. For example, in themulti-
ciliate Tetrahymena, new basal bodies are formed close to their
mothers so that new cilia form within cortical rows with the right
orientation in the right place. When centrioles form de novo in cil-
iates, they are not equally distributed across the cortex, and the
organism can show transient defective motility (Shang et al.,
2002).
Is PLK4 the only centriole component whose biochemical
properties provide spatial constraints to centriole biogenesis?
While the last common ancestor of eukaryotes was likely to
have centrioles/basal bodies and molecules that are necessary
for its biogenesis, such as SAS-6, PLK4 only exists in Opisto-
khonts (animals and fungi) (Carvalho-Santos et al., 2010,
2011). It is possible that other kinases, such as the ancestral
member of the Polo kinase family, played the same role and
were regulated in a similar concentration-dependent manner.
Other centrosome components may also be regulated in a
similar fashion; indeed, SAS-6 is present in the cytoplasm pri-
marily as a homodimer and its oligomerization into a centriole
precursor structure occurs upon its concentration at centrioles
(Keller et al., 2014).
PLK4 is upregulated and associated with bad prognosis in
breast cancer, and its deregulation causes microcephaly and
cancer (Marthiens et al., 2013; Mason et al., 2014). Significantly,
inhibitors of this kinase have been recently reported and are now
in clinical trials for breast cancer treatment (Mason et al., 2014;
Wong et al., 2015). Understanding how PLK4 activity is regulated
is thus critical to understand the effects of drugs that target this
enzyme, the potential mechanisms of resistance to beFP-PLK4(WT) was immunoprecipitated and sequentially detected on western
ount of PLK4 is shown; ratios were normalized to mCherry PLK4(WT) control.
ells expressing different amounts of pMT-GFP-PLK4(WT) or GFP-PLK4(SKL)
os of p-PLK4-Thr172 to the total amount of PLK4 loaded are shown. The ratios
4 bands detected, including all the reduced gel mobility bands, were used for
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Figure 6. High Levels of PLK4 Can Overcome the Inhibition of De Novo Biogenesis
(A) Scheme of early stages of Drosophila spermatogenesis. The division of a stem cell forms a gonial cell that undergoes four rounds of incomplete mitotic
divisions to produce a cyst of 16 primary spermatocytes. Primary spermatocytes undergo a long G2 phase, during which two pairs of centrioles elongate to form
very long centrioles (1.25 mm).
(B) PLK4 overexpression levels can be controlled in vivo. Quantification of total overexpressed GFP-PLK4 levels in whole mounted testes of flies grown at
different temperatures (16C to 25C). a.u., arbitrary units.
(legend continued on next page)
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Figure 7. Distribution of Active PLK4
Controls Different Pathways of Centriole
Assembly in a Cell
(A and B) Schematic representation of the different
pathwaysof centriole formation in cellswith (A) and
without (B) pre-existing centrioles, according to
varying levels of PLK4. (A) In a cell with a pre-ex-
isting centriole, we described three possibilities of
centriole formation: (i) in WT cells, endogenously
expressed PLK4 is concentrated and thus acti-
vated at the existing centriole, leading to canonical
centriole biogenesis; (ii) at low levels of PLK4
overexpression (OE), higher amounts of PLK4
concentrate and activate at the existing centriole,
therefore promoting canonical centriole amplifi-
cation (rosette-like), (iii) at higher levels of PLK4
overexpression, PLK4’s concentration is sufficient
to promote its activation at the centrosome as well
as in the cytoplasm, leading to both canonical and
de novo amplification. (B) In a cell naturally without
centrioles, such as the WT unfertilized Drosophila
egg, PLK4 is expressed at endogenous levels and
no centrioles are formed de novo (Rodrigues-
Martins et al., 2007); upon PLK4 overexpression,
de novo amplification occurs (Rodrigues-Martins
et al., 2007), presumably because PLK4 levels in
the cytoplasmare sufficiently high to activate.Note
that in human cultured cells de novo biogenesis
can occur without overexpression of PLK4 (La
Terra et al., 2005). The mechanism underlying this
phenomenon is still unknown; perhaps these cells
have intrinsically higher endogenous PLK4 levels,
or centrosome removal could lead to upregulation
of PLK4.counteracted and to rationally define which tumors are drug sen-
sitive. Markers of PLK4 activity, such as phosphorylation of the
activation T-loop residue described in this work, might also be
used to aid in patients’ stratification for clinical decisions,
including whether to enroll in surveillance programs and choice
of therapy.
EXPERIMENTAL PROCEDURES
Plasmid Constructs
All the vectors used in this study were constructed using the Gateway system
(Invitrogen). PLK4 Kinase Dead (KD) includes mutations K43M, K22M, and
D156A (Rodrigues-Martins et al., 2008). Non-degradable PLK4(ND) includes
mutations S293A and T297A (Cunha-Ferreira et al., 2009). PLK4(KDND)(C–F) Varying levels of PLK4 overexpression lead to different pathways of cent
overexpressing different levels of GFP-PLK4. A representative image of a contro
features at all temperatures (data not shown). Centrioles and DNA aremarked usin
red) and DAPI (blue), respectively. Insets show enlargements of centrosomes ind
total number of centrioles per spermatocyte from the flies grown at different tempe
types observed, classified according to their number of centrosomes and centriol
of two centrioles (only observed in control cells); (2) type II (never observed): sper
(containing 2 centrioles) and others containing only single centrioles; (3) type III: s
centrioles, i.e., three to seven centrioles in a rosette-like configuration; (4) type I
configuration and the remaining centrosome containing one to seven centrioles. A
and reduplicate further, we saw supernumerary centrosomes early in the 16 ce
Presently, it is also difficult to assert whether the de novo formed centrioles withi
novo and others subsequently amplify canonically within a centrosome. (F) Quan
the two WT centrosomes) observed per spermatocyte at different PLK4 levels. T
represent ± SD in all graphs.
232 Developmental Cell 35, 222–235, October 26, 2015 ª2015 Elsevmutant includes K43M, K22M, D156A, and S293A and T297A (Cunha-Ferreira
et al., 2013). To create the PLK4(T172A) and PLK4(SKL) mutants, we used the
Quick Change XL Site-Directed mutagenesis kit (Stratagene) according to the
manual. In PLK4(SKL), the tripeptide sequence Ser-Lys-Leu was added at
the C terminus region of PLK4, as previously described (Gould et al., 1989).
Detailed information on constructs and primers used are in Supplemental
Information.
Cell Culture and Transfections
Drosophila (DMEL) cells were cultured in Express5 SFM (GIBCO) supple-
mented with 13 L-Glutamine-Penicillin-Streptomycin. dsRNA synthesis was
performed as previously described (Bettencourt-Dias et al., 2004). Transient
plasmid transfections were performed with Effectene reagent (QIAGEN) ac-
cording to the manual. In experiments where the cells had previously been
treated with dsRNA, plasmid transfection was performed on the second dayriole assembly in vivo. (C) Representative images of primary spermatocytes
l spermatocyte grown at 25C is shown. Control flies always displayed these
g RFP-PACT (PACT is the centriole-targeting domain ofDrosophila pericentrin,
icated by the arrowheads. Scale bar represents 5 mm. (D) Quantification of the
ratures. (E) The histogram shows the percentage distribution of all different cell
es: (1) type I: spermatocytes containing only two centrosomes, each consisting
matocytes having more than two centrosomes, two with WT-like configuration
permatocytes showing only two centrosomes, each containing supernumerary
V: spermatocytes containing at least three centrosomes, two in a rosette-like
lthough it is formally possible that some centrioles could break from a rosette
lls stage, supporting the conclusion that most clusters are formed de novo.
n a centrosome form all at the same time or whether some centriole(s) form de
tification of the total number of supernumerary centrosomes (i.e., additional to
he centriole numbers in these centrosomes vary from one to seven. Error bars
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of depletion. In transfections with pMT-derived constructs, induction with
CuSO4 was initiated 15 hr before harvesting. Detailed descriptions of
dsRNA/plasmid transfections and primers used are in Supplemental
Information.
Preparation of Cell Extracts and Western Blotting
Whole-cell lysates were prepared by resuspending cell pellets in lysis buffer:
75 mM HEPES (pH 6.8), 150 mM NaCl, 2 mM MgCl2, 0.1% NP-40, 5 mM
DTT, 5% glycerol, 2 mM EGTA, phosphatase inhibitors (200 mM NaF,
150 mM b-glycerophosphate, 1 mM Na3VO4) (all chemicals from Sigma),
and 13 EDTA-free protease inhibitors (Roche). Laemmli buffer was added
to 13, and samples were boiled at 99C for 5 min before being analyzed
by SDS-PAGE. The lysate soluble and insoluble fractions were separated
by centrifugation at 14,000 rpm for 10 min. The pellet was resuspended in
0.8 M urea and 13 Laemmli buffer and then boiled at 99C for 5 min before be-
ing analyzed by SDS-PAGE. Standard western blotting procedures are
described in Supplemental Information.
Phosphatase Treatments
Whole-cell lysates were treated for 30 min at 30Cwith 400 U of lambda phos-
phatase (New England Biolabs) or lambda phosphatase plus phosphatase in-
hibitors (in lysis buffer) in 13 phosphatase buffer supplemented with 1 mM
MnCl2. After treatment, cell extracts were prepared as described above.
Recombinant PLK4 Expression and In Vitro Autophosphorylation
Expression of recombinant pGEX-2RBS-GST-PLK4(WT) and pGEX-2RBS-
GST-PLK4(KD) and of recombinant dephosphorylated His-MBP-PLK4(WT) is
detailed in Supplemental Information. For in vitro autophosphorylation assays,
50 to 800 mMHis-MBP-PLK4 were incubated for 10min at 18C in 50mM Tris-
HCl (pH 7.5) buffer with 1 mM ATP and 1 mM MgCl2.
Immunoprecipitation
Ten million cells were transiently transfected with pMT-GFP-PLK4(WT) or
pMT-GFP-PLK4(SKL) and dsRNA against mCherry or SAS-6 and were
induced with 150 mM CuSO4 for 15 hr. Cell pellets, washed in PBS with prote-
ase inhibitors, were snap frozen in liquid nitrogen and then resuspended in 1ml
lysis buffer followed by four freeze-thaw cycles. After centrifuging (14,000 rpm,
30 min), the supernatant was incubated with 80 ml of GFP-Trap beads (Chro-
motek for 3 hr at 4C. Beads were washed four times in lysis buffer, resus-
pended in 13 Laemmli buffer in lysis buffer, and prepared for analysis by
SDS-PAGE.
Immunostaining and Centrosome Scoring
Immunostainingwas performed as previously described (Cunha-Ferreira et al.,
2013). Cells were mounted with Vectashield containing DAPI (Vector Labora-
tories). Cell imaging was performed on Leica DMRA2 or Nikon Eclipse Ti-E
microscopes with Cool SNAP HQ or Evolve EMCCD cameras, respectively
(Photometrics), controlled byMetaMorph7.5 software (MolecularDevices). Im-
ages were acquired as a Z-series (0.3 mm z interval) and are presented as
maximal intensity projections. Super-resolution-structured illumination images
were acquired using the Zeiss LSM780 ELYRA PS1 (SR-SIM) microscope with
a633oil objective. Imageswere collected andprocessed usingZeiss Zen soft-
ware. Centrioles were scored in a total of 100 cells per sample per experiment.
Phospho-Specific and Other Antibodies
Rabbit p-PLK4 Thr172 polyclonal antibody was synthesized, purified, and pur-
chased from PhosphoSolutions. Short phospho-peptide spanning the Thr172
residue was used for the production of the antibody. The antibodies used for
western blotting and immunostaining are listed in Supplemental Information.
Fly Stocks and Husbandry
Control (RFP::PACT/UASGFP::PLK4; +/+) and PLK4 overexpressing
(RFP::PACT/UASGFP::PLK4; BamGal4/+) flies (Cunha-Ferreira et al., 2013)
were grown in normal corn meal media at different temperatures as indicated.
Testes Sample Preparation, Imaging, and Analysis
To measure the total amount of PLK4, intact testes from 0- to 1-day-old adult
males expressing GFP::PLK4 were dissected in testes buffer (183 mM KCl,Developm47 mMNaCl, 1 mM EDTA, and 10 mM Tris-HCl [pH 6.8]) and fixed in 4% form-
aldehyde for 20 min. Intact testes were then washed and mounted using
Vectashield and were imaged on a Leica SPX5 microscope; total GFP fluores-
cence in the whole testes was measured using Imaris 7.7. To study centrioles,
squash preparations of testes from 0- to 1-day-old adults were done as previ-
ously described (Cenci et al., 1994; Cunha-Ferreira et al., 2013). Samples were
imaged as a Z-series (0.3 mm z-interval and 0.04 mm XY-pixel size) on a Leica
SPX5 microscope. Images are presented as 3D projections using Imaris 7.8.
Mathematical Modeling
We developed two models describing PLK4 dynamics in three forms: non-
phosphorylated PLK4, active PLK4 phosphorylated in Thr172 (T-loop) and fully
active PLK4 phosphorylated in both Thr172 and degron. The first model ana-
lyzes the kinetics of cis- and trans-activation assuming these reactions occur
in a single compartment. The second model features only trans-activation and
assumes the reactions occur in two compartments: cytoplasm and centro-
some. The latter model was used to analyze the dual effects of PLK4 overex-
pression and centrosome ablation. The models were formulated as differential
equations and analyzed with Mathematica 4.2 software (Wolfram Research).
For details, see Supplemental Information.
Statistical Analysis
All the statistical analysis, Pearson’s c2 test and t-test, was performed with
Graphpad Prism version 5.0 software.
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